05.04.2019 13:42:01
|
Endo Unit Begins Shipping Generic Version Of Merck's PROVENTIL - Quick Facts
(RTTNews) - Endo International plc (ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping an authorized generic version of Merck's PROVENTIL (albuterol sulfate) HFA Inhalation Aerosol, 120mcg. Endo said its subsidiary, Endo Procurement Operations, recently entered into an exclusive U.S. supply and distribution agreement with a subsidiary of Merck & Co., Inc. allowing Par to launch and distribute an authorized generic of the product.
Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets cost-effective generic pharmaceutical and branded injectable products.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Endo International plcmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Endo International plcmehr Analysen
Aktien in diesem Artikel
Merck Co. | 85,00 | 2,29% |
|